source
- Roche receives expanded FDA clearance for HER2 diagnostic tests linked to Jazz’s Ziihera cancer drugRoche announced that the U.S. Food and Drug Administration has broadened the clearance for two of its HER2 diagnostic assays, allowing their use in metastatic gastroesophageal adenocarcinoma. The…
- UK reduces drug rebate rate to 14.5% after a year of pharma pull-back, following US trade dealIn September 2025, relations between the UK government and major pharmaceutical companies hit a low point when the government announced a steep increase in the share of sales of new branded medicin…